The 10-second takeaway
Comparing the upcoming quarter with the prior-year quarter, average analyst estimates predict Henry Schein's revenues will grow 3.7% and EPS will increase 8.9%.
The average estimate for revenue is $2.21 billion. On the bottom line, the average EPS estimate is $1.10.
Last quarter, Henry Schein notched revenue of $2.10 billion. GAAP reported sales were 7.8% higher than the prior-year quarter's $1.95 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.98. GAAP EPS of $0.89 for Q1 were 8.5% higher than the prior-year quarter's $0.82 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 29.1%, 10 basis points better than the prior-year quarter. Operating margin was 6.9%, 50 basis points better than the prior-year quarter. Net margin was 3.8%, 10 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $8.98 billion. The average EPS estimate is $4.37.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 93 members out of 103 rating the stock outperform, and 10 members rating it underperform. Among 35 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give Henry Schein a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Henry Schein is hold, with an average price target of $75.54.
If you're interested in health care stocks like Henry Schein, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Get instant access to this free report.
- Add Henry Schein to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is the co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.